Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
Once again, teamwork makes the (HFrEF) dream work. Engage your pharmacists, they help overcome clinical inertia and improve GDMT.
jacc.org/doi/epdf/10.1016/j.…
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
📢 Generic Entresto is now available at Cost Plus Drugs ❗️
Sacubitril/Valsartan is now on costplusdrugs.com. A big step forward for those managing chronic heart failure.
Available in:
💊 24mg/26mg 30 tablets - $33.75 - costplusdrugs.com/medication…
💊 49mg/51mg 30 tablets - $33.75 - costplusdrugs.com/medication…
💊 97mg/103mg 30 tablets - $33.75 - costplusdrugs.com/medication…
➡️ No membership fees. No insurance needed. Just transparent pricing! Sign up today at costplusdrugs.com/create-acc…
⭐️ Thank you to Ascend Laboratories for making this possible!
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
🚨New in @JACCJournals w #ACC24
🇺🇸 analysis of newly diagnosed #HFrEF
>4 in 5 pts eligible for quad GDMT
Yet, <1 in 6 prescribed it.
Potentially completely generic triple GDMT (RASi + BB + MRA)??.....only ~4 in 10 eligible pts even prescribed this.
jacc.org/doi/10.1016/j.jchf.…
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
Registration now open! Join us for a discussion of how the new #AFib guidelines pertain to #anticoagulation practitioners 💓
Wednesday, Feb. 21, 12pm ET
Moderators & panelists: @AAllenPharmD @AVB_AnticoagNP @AArmbruster09 ❤️🔥
Register today! bit.ly/3SFdnqT
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis & Management of #AFib provides updated guidance for clinicians and emphasizes a rhythm control strategy & the need for lifestyle & risk factor modification in addition to medical treatment. Read the full guideline: bit.ly/3T1vxnh
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
Now this is how to do an assessment of value for pharmacists' services! We need more formal CEAs like this based on patient outcomes (⬇︎BP ➡︎ ⬇︎ CVD events) & less cost-avoidance studies based on interventions made. Kudos @VCUDPOSChair & coauthors. jamanetwork.com/journals/jam…
New academic year, new title! I was promoted to the academic rank of Professor and was honored to receive the Joe E. Haberle Outstanding Educator of the Year award. Lucky to work with great people, teach great students and residents, and have a rewarding clinical practice!
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
TUNA2 for antithrombotic stewardship. Does your hospital have a process for identifying which patients are at increased risk of bleeding and could benefit from ASA deprescribing or initiation of PPI. Thanks @jekurlander for this great graphic! #ACForum23 @AnticoagForum – at San Francisco, CA
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
Replying to @MissouriACC
@MissouriACC Dr Deana Mikhalkova discussing the Heart Failure Guidelines @ACCinTouch @MinnowWalsh @HadleyWilsonMD @DrKLindley @SriPittaMD @Santhosh_Mannem @AArmbruster09
Pharmacists highlighted as a critical member of the heart team. Dr. Walsh also highlighted training and certifications clinical pharmacists complete. @MissouriACC @ACCinTouch #cvteam
The OG heart team? Heart failure! @MinnowWalsh @MissouriACC
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
Replying to @ACCinTouch
@ACCinTouch @MinnowWalsh - Keynote - Discussing the importance of the team and team based care @DrKLindley @HadleyWilsonMD @SriPittaMD @vtrivediMBBS @AnnaGrodzinsky @AArmbruster09 @MissouriACC
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
Replying to @ACCinTouch
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
Top3 heart failure trials in October 2022: #CardioTwitter
🥇Managing HF in patients on dialysis @JCardFail
🥈 Hydrochlorothiazide vs chlorthalidone, what is the difference? @CircAHA
🥉HF drug treatment ➡️Inertia, y itration, and discontinuation: EVOLUTION HF @JACCJournals
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
This is an excellent overview of treating patients with ASCVD and other comorbidities!
Will unapologetically highlight the role of an expert #Pharmacist Dr. Kim Birtcher on the writing committee 💪
American College of Cardiology shares expert analysis on treating #ASCVD patients with multiple chronic conditions @UH_Pharmacy @UHouston @ACCmediacenter @ACCinTouch #cardiology #CVD ow.ly/lwPz50LmNlL
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
#PharmD + @ACCinTouch = 🫀
Please share with your PharmD colleagues to join ACC and the #ACCCVT this month. They will receive a 40% discount for 2023!
Code: YouSave40
@beaverspharmd shares about the value of being a part of ACC
@ASchenkPharmD @accpcardprn @AArmbruster09
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
Why simultaneous, early in-🏨 initiation of foundational #GDMT should be the standard of care globally
@SJGreene_md @JavedButler1 @robmentz @NMHheartdoc @MarcoMetra
Initiation of novel #GDMT at dischsrge in #HF is delayed compared with other Rx. Few patients received target doses of GDMT requiring up-titration. Persistence was ⬆️ for dapagliflozin than other GDMTs 👉 https://nitter.cf/t.co/RxyU3rl7oG #MedEd #CardioTwitter @AndrewJSauer @JACCJournals
Clinical Pharmacist/Dobutamine police. Not enough filter to make it look like I got a good nights sleep
2
48
US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution? tctmd.com/news/us-dobutamine…
1
Anastasia Armbruster, Pharm.D., FACC, BCCP retweeted
The recent SCOTUS ruling will have a profound impact on the lives of my patients. On the lives of all of our patients. I had the opportunity to share my experience with pregnancy termination in my practice
To Save a Dying Mother tctmd.com/news/save-dying-mo…




































